Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Cancer centres and hospitals at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

36 cancer centres and hospitals are at SITC 2026 — 35 presentations on the program and 1 with a booth in the exhibit hall. Most represented: Dana-Farber Cancer Institute (6 on the program), Massachusetts General Hospital (6 on the program), MD Anderson Cancer Center (5 on the program). 20 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–9 of 36 organizations

Organization	SITC 2026 Attendance
Dana-Farber Cancer Institute Boston, MA
dana-farber.org Cancer centres & hospitals Harvard-affiliated cancer treatment and research center in Boston.	Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships 5:00pm–5:45pmWelcome Reception 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders 6:55pm–7:15pmPanel 7:00pm–7:50pmFinancing and Partnership Panel 8:00pm–9:00pmClosing Networking Reception Plenary Fri Nov 6 8:40am–9:10am Part of Session 102: Richard V. Smalley Memorial Award and Lectureship Getting Off the Rollercoaster: Personalized Cancer Vaccines Come of Age Halls BC Vaccines Plenary Fri Nov 6 11:10am–11:30am Part of Session 103: Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future The Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic Antigens Halls BC Vaccines Session Fri Nov 6 9:40am–11:30am Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future Halls BC Vaccines 9:44am–10:04amDiscovery and Development of a Pancreatic Cancer RNA VaccineMemorial Sloan Kettering Cancer Center 10:04am–10:24amUpdates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras VaccineScripps Research 10:24am–10:37amAbstract presentation — title not yet released 10:37am–10:57amLearning from Checkpoint Blockade: Prioritizing Neoantigens and Shared Tumor Antigens for Cancer VaccinesUniversity of Toulouse 10:57am–11:10amAbstract presentation — title not yet released 11:10am–11:30amThe Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic AntigensDana-Farber Cancer Institute Talk Fri Nov 6 2:10pm–2:30pm Part of Session 106a: Combination Therapies Involving Cell Therapy CAR-Enhancers: Programmable Boosters for Durable Cell Therapy Halls BC Cell therapy Talk Fri Nov 6 2:30pm–2:45pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Dynamic Immune Profiling Using Human Ex Vivo Tumor Models 301A Models & tech Session Sat Nov 7 5:20pm–6:40pm Oral Abstract Session 4 301D 5:20pm–6:35pm5 abstract presentations — titles not yet released
Massachusetts General Hospital Boston, MA
massgeneral.org Cancer centres & hospitals Harvard teaching hospital in Boston and home of the Mass General Cancer Center.	Session Thu Nov 5 12:00pm–1:30pm Collaborating with Industry Encanto AB Session Fri Nov 6 1:45pm–3:25pm Mechanisms of irAEs Hall A Clinical 1:50pm–2:10pmDiet and Microbiome Drivers of Immune Related Adverse EventsUniversity of Pittsburgh 2:10pm–2:30pmUnlocking the Specificity of the Autoimmune Response in iRAE’sUCSF 2:30pm–2:50pmClinical Trials for irAEs: Where Do We Go Next?Vanderbilt University Medical Center 2:55pm–3:25pm2 abstract presentations — titles not yet released Talk Sat Nov 7 4:15pm–4:25pm Part of Session 206c: Microbiome and Metabolism Gut Microbiota Metabolite Control of Antitumor CD8 T Cell Trafficking 301A Tumor biology Session Sat Nov 7 3:30pm–4:50pm IO in Low Mutation Burden Cancers Hall A Tumor biology 3:35pm–3:55pmTargeted Therapy + ImmunotherapyJohns Hopkins University 3:55pm–4:15pmFrom the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint TherapyMD Anderson Cancer Center 4:15pm–4:35pmBeyond the Canonical Proteome: Identifying Immunogenic Targets in Ovarian TumorsMayo Clinic 4:35pm–4:50pmAbstract presentation — title not yet released Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Talk Sat Nov 7 5:40pm–5:55pm Part of Session 207d: Cellular Therapies Learnings From a CAR-T Driver Into Solid Tumor Halls BC Cell therapy Talk Sun Nov 8 10:45am–11:00am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology of anti-VEGF treatment Hall A New agents · Tumor biology
MD Anderson Cancer Center Houston, TX
mdanderson.org Cancer centres & hospitals University of Texas comprehensive cancer center in Houston focused on cancer patient care, research and education.	Session Thu Nov 5 12:00pm–1:30pm Career Paths for Physician Scientists Encanto AB Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Talk Sat Nov 7 10:00am–10:20am Part of Session 202: Spatial Biology Spatial Biomarkers of Immunotherapy Response Halls BC Biomarkers · Models & tech Talk Sat Nov 7 3:55pm–4:15pm Part of Session 206b: IO in Low Mutation Burden Cancers From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy Hall A Tumor biology Session Sat Nov 7 3:30pm–4:50pm Oral Abstract Session 3 301D 3:30pm–4:45pm5 abstract presentations — titles not yet released Talk Sun Nov 8 11:30am–11:45am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology and Clinical Results of Anti-VEGF+PD1 Bispecfics Hall A New agents
Brigham and Women's Hospital Boston, MA
brighamandwomens.org Cancer centres & hospitals Harvard-affiliated academic medical center in Boston, part of Mass General Brigham.	Session Thu Nov 5 12:00pm–1:30pm How to Navigate the Graduate Student to Postdoc Transition Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: F Grants and T Grants for Predoctoral /Medical Students and Early Postdocs Encanto AB Talk Fri Nov 6 2:45pm–3:05pm Part of Session 106c: Immunosenescence How Age Shapes Breast Cancer Immunity, Therapeutic Response, and Outcomes 301BC Tumor biology Session Fri Nov 6 1:45pm–3:25pm Oral Abstract Session 1 301D 1:45pm–3:23pm7 abstract presentations — titles not yet released Session Sat Nov 7 3:30pm–4:50pm New Avenues in Myeloid Cells Halls BC Tumor biology 3:30pm–3:50pmLeveraging Single-Cell Technologies to Engineer the Immune SystemWeizmann Institute of Science 3:50pm–4:10pmNeutrophilsJohns Hopkins University 4:10pm–4:30pmLILRB CheckpointsWashington University in St. Louis 4:30pm–4:50pm2 abstract presentations — titles not yet released Talk Sat Nov 7 6:20pm–6:40pm Part of Session 207c: Hot and Cold Tumors Hot and Cold Tumor Debate Hall A Tumor biology
Fred Hutchinson Cancer Center Seattle, WA
fredhutch.org Cancer centres & hospitals Cancer research and treatment center in Seattle, known for bone marrow transplantation and cellular immunotherapy.	Session Thu Nov 5 12:00pm–1:30pm Bioinformatics, Big Data, and AI (Table 2) Encanto AB AI & data Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Sat Nov 7 11:45am–12:05pm Part of Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Debate: Pros and Cons on Time of Day and Checkpoint Inhibitors Halls BC Clinical Talk Sat Nov 7 3:45pm–4:00pm Part of Session 206d: Novel Paradigms for Effectively Combining Immunotherapies with Radiopharmaceuticals or Radiation Therapy Distinct Immune Responses Induced by Different Forms of Radiotherapy Combined with Immune Checkpoint Inhibition 301BC Clinical
Peter MacCallum Cancer Centre Melbourne, Australia
petermac.org Cancer centres & hospitals Australian public cancer hospital and research centre in Melbourne.	Talk Sat Nov 7 4:00pm–4:15pm Part of Session 206d: Novel Paradigms for Effectively Combining Immunotherapies with Radiopharmaceuticals or Radiation Therapy Radioligand Therapy + Immunotherapy: Translating Biology to Benefit 301BC Clinical Talk Sat Nov 7 5:37pm–5:52pm Part of Session 207a: Sex-specific Factors that Influence Immune Fitness and Response to Immunotherapy Breast Cancer Anti-Tumour Immunity and Reproductive History 301A Tumor biology Session Sat Nov 7 5:20pm–6:40pm Sex-specific Factors that Influence Immune Fitness and Response to Immunotherapy 301A Tumor biology 5:22pm–5:37pmBreast Cancer Risk in the Early Post-Partum PeriodUniversity of Colorado 5:37pm–5:52pmBreast Cancer Anti-Tumour Immunity and Reproductive HistoryPeter MacCallum Cancer Centre 5:52pm–6:07pmSex Differences and Cancer EtiologyCedars-Sinai 6:07pm–6:27pm2 abstract presentations — titles not yet released
Mayo Clinic Rochester, MN
mayoclinic.org Cancer centres & hospitals Academic medical centre with campuses in Minnesota, Arizona and Florida and an NCI-designated comprehensive cancer centre.	Talk Fri Nov 6 2:30pm–2:50pm Part of Session 106a: Combination Therapies Involving Cell Therapy Re-charging CAR T Cells Through Their TCR with Oncolytic Viruses. Halls BC Cell therapy · Vaccines Talk Sat Nov 7 4:15pm–4:35pm Part of Session 206b: IO in Low Mutation Burden Cancers Beyond the Canonical Proteome: Identifying Immunogenic Targets in Ovarian Tumors Hall A Tumor biology
Netherlands Cancer Institute Amsterdam, Netherlands
nki.nl Cancer centres & hospitals Comprehensive cancer centre combining a research institute and the Antoni van Leeuwenhoek hospital.	Talk Fri Nov 6 2:15pm–2:30pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Personalizing Cancer Immunotherapy Using Patient-Derived Tumor Models 301A Models & tech Plenary Sat Nov 7 8:30am–9:00am Part of Session 201: Keynote Address T Cell Recognition of Human Cancer: 'Cracking the Code’ Halls BC Tumor biology
Winship Cancer Institute of Emory University Atlanta, GA
winshipcancer.emory.edu Cancer centres & hospitals NCI-designated comprehensive cancer center at Emory University in Atlanta.	Session Thu Nov 5 12:00pm–1:30pm Navigating Academia as Junior Faculty (as MD or PhD) Encanto AB Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Transition from Mentored to Independent Grants (Getting Your First R01) Encanto AB